The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice

MLA

Ronald F van Vollenhoven, et al. “The Cost-Effectiveness of TNF-Inhibitors for the Treatment of Rheumatoid Arthritis in Swedish Clinical Practice.” The European Journal of Health Economics, vol. 14, Sept. 2012, pp. 863–73. EBSCOhost, https://doi.org/10.1007/s10198-012-0431-6.

APA

Ronald F van Vollenhoven, Jörgen Lysholm, Fredrik Borgström, Staffan Lindblad, Pierre Geborek, Gisela Kobelt, & Ingrid Lekander. (2012). The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice. The European Journal of Health Economics, 14, 863–873. https://doi.org/10.1007/s10198-012-0431-6

Chicago

Ronald F van Vollenhoven, Jörgen Lysholm, Fredrik Borgström, Staffan Lindblad, Pierre Geborek, Gisela Kobelt, and Ingrid Lekander. 2012. “The Cost-Effectiveness of TNF-Inhibitors for the Treatment of Rheumatoid Arthritis in Swedish Clinical Practice.” The European Journal of Health Economics 14 (September): 863–73. doi:10.1007/s10198-012-0431-6.